Effect of hormonal replacement therapy on C-reactive protein and cell-adhesion molecules in postmenopausal women

American Journal of Cardiology

Volumn 91, Issue 2, 2003, Pages 252-254

  Lamon Fava, Stefania ^a   Posfai, Borbala ^a   Schaefer, Ernst J ^a  

^a TUFTS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CELL ADHESION MOLECULE; CONJUGATED ESTROGEN; INTERCELLULAR ADHESION MOLECULE 1; MEDROXYPROGESTERONE ACETATE; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; ANAMNESIS; ARTICLE; BLOOD ANALYSIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HORMONE SUBSTITUTION; HUMAN; IMMUNOASSAY; INFORMED CONSENT; LIFESTYLE; MENOPAUSAL SYNDROME; PATIENT SELECTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

C-REACTIVE PROTEIN; CELL ADHESION MOLECULES; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; ESTROGEN REPLACEMENT THERAPY; ESTROGENS, CONJUGATED (USP); FEMALE; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; MEDROXYPROGESTERONE 17-ACETATE; MIDDLE AGED; PLACEBOS; POSTMENOPAUSE; PROGESTERONE CONGENERS; VASCULAR CELL ADHESION MOLECULE-1;

EID: 0037299633     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(02)03121-1     Document Type: Article

References (15)

1. Hulley S.B., Grady D., Bush T., Furberg C.D., Herrington D.M., Riggs B., Vittinghoff E. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA. 280:1998;605-613.
2. Herrington D.M., Reboussin D.M., Brosnihan B., Sharp P.C., Shumaker S.A., Snyder T.E., Furberg C.D., Kowalchuk G.J., Stuckey T.D., Rogers W.J., Givens D.H., Waters D. Effects of estrogen replacement on the progression of coronary-artery atherosclerosis. N Engl J Med. 343:2000;522-529.
3. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA. 288:2002;321-333.
4. Psaty B., Smith N., Lemaitre R., Vos H., Heckbert S., LaCroix A., Rosendaal F. Hormone replacement therapy, prothrombotic mutations, and the risk of incident nonfatal myocardial infarction in postmenopausal women. JAMA. 285:2001;906-913.
5. Cushman M., Legault C., Barrett-Connor E., Stefanick M., Kessler G., Judd H., Sakkinen P., Tracy R. Effect of postmenopausal hormones on inflammation-sensitive proteins the Postmenopausal Estrogen/Progestin Interventions (PEPI) study. Circulation. 100:1999;717-722.
6. Ridker P.M., Hennekens C.H., Rifai N., Buring J.M., Manson J.A. Hormone replacement therapy and increased plasma concentration of C-reactive protein. Circulation. 100:1999;713-716.
7. Ridker P.M., Stampfer M.I., Rifai N. Novel risk factors for systemic atherosclerosis a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease. JAMA. 285:2001;2481-2485.
8. Koenig W., Sund M., Frohlich M., Fischer H., Lowel H., Doring A., Hutchinson W., Pepys M. C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary disease in initially healthy middle-aged men results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. Circulation. 99:1999;237-242.
9. Wakatsuki A., Okatani Y., Ikenoue N., Fukaya T. Effect of medroxyprogesterone acetate on vascular inflammatory markers in postmenopausal women receiving estrogen. Circulation. 105:2002;1436-1439.
10. Scarabin P., Alhene-Gelas M., Oger E., Plu-Bureau G. Hormone replacement therapy and circulating ICAM-1 in postmenopausal women. A randomized controlled trial. Thromb Haemost. 81:1999;673-675.
11. Herrington D.M., Brosnihan B., Pusser B., Seely E., Ridker P.M., Rifai N., MacLean D. Differential effects of E and droloxifene on C-reactive protein and other markers of inflammation in healthy postmenopausal women. J Clin Endocrinol Metab. 86:2001;4216-4222.
12. Koh K., Bui M., Mincemoyer R., Cannon R. III. Effects of hormone therapy on inflammatory cell adhesion molecules in postmenopausal women. Am J Cardiol. 80:1997;1505-1507.
13. Koh K., Jin D., Yang S., Lee S., Hwang H., Kang M., Kim W., Kim D., Choi I., Shin E. Vascular effects of synthetic or natural progestagen combined with conjugated equine estrogen in healthy postmenopausal women. Circulation. 103:2001;1961-1966.
14. Singh A., Hsia S., Alaupovic P., Sinha-Hikim I., Woodhouse L., Buchanan T., Shen R., Bross R., Bernam N., Bhasin S. The effects of varying doses of T on insulin sensitivity, plasma lipids, apolipoproteins, and C-reactive protein in healthy young men. J Clin Endocrinol Metab. 87:2002;136-143.
15. Skouby S., Gram J., Andersen L., Sidelmann J., Petersen K., Jespersen J. Hormone replacement therapy estrogen and progestin effects on plasma C-reactive protein concentrations. Am J Obst Gyn. 186:2002;969-977.